The presented analytical dose calculation algorithm is applicable for any type of heterogeneity. The high calculation speed of the algorithm makes it feasible for use in clinical real timetreatment planning and thus for improving treatment quality. (IsoSeed, Bebig). Loose seeds (LS) were delivered automatically with the seedSelectron system, while stranded seeds (SS) were placed into the prostate manually. For treatment planning the SPOT PRO 3.1 (Nucletron) software was used for all patients. The number and positions of seeds were calculated with an inverse dose optimization algorithm (IPSA) in the pre-implant plan. Then, the seeds were implanted under transrectal ultrasound guidance, and their real positions were updated in live planning. The prescribed dose was 145 Gy. Dose-volume histograms were calculated and volumetric parameters were used to evaluate the plans. V100 (%), DHI, D90 (Gy) and COIN were determined for the prostate, while D max (%), D0.1cm 3 (%), D10 (%), D30 (%) for the urethra, and D max (%), D0.1cm 3 (Gy), D2cm 3 (Gy), D10 (%) for the rectum. Means and standard deviations were calculated and compared for both intervention groups. Results: On average, 54 and 47 seeds were implanted in the prostate with individual median seed activities of 0.49 and 0.56 mCi for LS and SS technique, respectively. The median needle number was 15 and 17, correspondingly. The mean prostate volumes were practically identical (33.4 vs. 33.9 cm 3 ). The dose coverage was similar (V100: 96% vs. 97%, D90: 167 Gy vs.169 Gy) in the two groups, and the dose homogeneity was identical (DHI: 0.39). Results: Survey data was acquired from 31 UK radiotherapy centres and statistical analysis of responses performed. 45 possible individual QC tests were identified. There was general agreement on measurement frequency and tolerance for key QC tests, e.g. measurement of source position in a straight catheter, checked daily and with a 1.0mm tolerance in most centres. There was disagreement on a number of tests, e.g. the need for regular x-ray imaging of applicators. There was absence of tests that may be deemed necessary for modern brachytherapy practice, e.g. confirmation of planned and delivered dose distributions. There is likely a need to move from a device-centred to a system-centred approach, using riskbased assessment methods to determine required QC testing, with emphasis on clinical processes rather than simple device operation. Table 1 provides sample key results from the work.
). The dose coverage was similar (V100: 96% vs. 97%, D90: 167 Gy vs.169 Gy) in the two groups, and the dose homogeneity was identical (DHI: 0.39). The conformity of dose distributions was better for LS (COIN: 0.70 vs. 0.65). Regarding the dose to urethra all dosimetric parameters were significantly lower (p<0.05) for LS (D max Results: Survey data was acquired from 31 UK radiotherapy centres and statistical analysis of responses performed. 45 possible individual QC tests were identified. There was general agreement on measurement frequency and tolerance for key QC tests, e.g. measurement of source position in a straight catheter, checked daily and with a 1.0mm tolerance in most centres. There was disagreement on a number of tests, e.g. the need for regular x-ray imaging of applicators. There was absence of tests that may be deemed necessary for modern brachytherapy practice, e.g. confirmation of planned and delivered dose distributions. There is likely a need to move from a device-centred to a system-centred approach, using riskbased assessment methods to determine required QC testing, with emphasis on clinical processes rather than simple device operation. Table 1 provides sample key results from the work.
Conclusions:
The only contemporary benchmark survey of HDR QC practice has been undertaken. The outcome of this work is a review of current practice against available recommendations, relevant recent changes in clinical brachytherapy techniques, and the use of modern quality process assessments. Recommendations for appropriate, optimised QC for HDR brachytherapy are made. 
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Conclusions:
The only contemporary benchmark survey of HDR QC Purpose/Objective: Since several years, Co-60 HDR afterloading sources are commercially available. The long half-life of Co-60 together with its comparable dose distributions to Ir-192 makes this type of sources economically attractive, especially in developing countries. However up to date protocols for brachytherapy dosimetry provide no explicit guidelines for verification of Co-60 source calibration by the clinical physicist. The purpose of this work was twofold: first, the verification procedures recommended for Ir-192 in three existing dosimetry protocols were applied to both Co-60 and Ir-192 sources in order to test their applicability with Co-60 sources. Second, the evaluation of the experiments was performed together with medical physicists trained in a joint education program between Universities in Germany and Bangladesh. Purpose of this step was to add practical experience in Brachytherapy physics, a subject for which the Bangladesh University so far has only very little access to treatment facilities. Materials and Methods: Three existing dosimetry protocols (IAEA-TECDOC-1274, DIN 6809-2, AAPM Report 41) were applied to Co-60 and Ir-192 sources to measure reference air kerma rate with ionization chambers using the procedures recommended for . Wherever the protocols give no correction factors for the chamber readings from Co-60 sources, equivalent factors from literature were used. Verification measurements were performed with three different experimental methods (with a cylindrical ionization chamber both in a solid phantom and free in air, and with a well chamber) and evaluated with all three protocols. The measurements were performed at two hospitals in Germany, and evaluated in parallel in by the groups in Germany and Bangladesh. The results are compared to the reference air kerma rates given in the source certificates.
Results:
The measurements with all protocols and methods are in good agreement both for Ir-192 and Co-60. The measured air kerma rates show deviations from the certificate values smaller than 1.2% for Ir-192 and 2.5% for Co-60-Sources. The measurements with the well chamber show the lowest deviations from the certificate value. The results of the experiments were published both in a German and in an Indian medical physics journal. Conclusions: Air kerma rate measurements for Co-60 HDR sources using the existing protocols are possible with accuracy sufficient to verify source calibration even though the protocols are not specifically designed for Co-60 measurements. The existing protocols for brachytherapy dosimetry are outdated. New protocols are desirable, based on measurements with ionization chambers calibrated in absorbed dose to water and providing the complete measurement procedure and correction formalism also for Co-60 sources. Joint evaluation of experiments by physicist at a teaching institution and physicists in training at a second institution can provide a valuable means to disseminate experience to institutions with missing experimental resources. (2000) and the AAPM TG186 report. Tissue density was set to 1 in all simulations. Dose was approximated by collision kerma and both water and tissue kerma in tissue (i.e. Kw,t and Kt,t) were scored using the *F2 surface flux tally. Results are expressed as % differences of Kw,t with homogeneous water (Kw,w) to quantify differences in attenuation and scatter, as well as % differences between Kt,t and Kw,w to quantify the combined effect of the attenuation and differences in mass energy absorption.
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Results:
When the effect of density is ruled out, differences in electron density and Z eff between air and water translate to negligible differences in attenuation (Kw,air is within 1% with Kw,w in contrast to Kair,air which is 10% lower due to the lower mass energy absorption of air). Dosimetric differences between lung and water are negligible regardless of kerma reporting in lung or water, albeit positive in the former case and negative in the latter. For soft tissue materials, Kw,t reporting would yield significant differences from water for high adipose content (lower O weight) only at increased distances. Kt,t reporting would yield negligible differences from water for all materials and distances. The connective and mean soft tissues all appear dosimetrically equivalent to water regardless of reporting Kw,t or Kt,t, except for mean adipose. Skeletal tissues present increasing differences from water with increasing proportion of osseous tissue to bone marrow, with negative differences for Kw,bone and positive for Kbone,bone. Conclusions: Lung and average soft tissue materials set forth by the AAPM TG186 are water equivalent for the 192 Ir energies regardless of kerma reporting material. Departure from water equivalence is only observed when Kw,t is reported and only for large tissue thickness. Kerma reporting material also affects the differences relative to water for skeletal materials. Tissue density is the determining parameter for individualized 192 Ir patient dosimetry. A method for stoichiometric CT calibration is not required unless reporting water kerma in the inhomogeneous geometry is of the essence.
